Multi-Herb Composition for Avian Influenza Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medications for avian influenza, such as neuraminidase inhibitors, ion channel blockers, and nucleotide medications, are either expensive, have significant side effects, or are ineffective against highly pathogenic strains, and existing Chinese traditional medicine compositions are not sufficient for preventing and treating avian influenza effectively.
Innovation Solution
A Chinese traditional medicine composition comprising herbs like Herba Houttuyniae, Caulis Lonicerae Japonicae, Radix Isatidis, Radix et Rhizoma Sophorae Tonkinensis, and other herbs, which are processed into various forms for oral or injectable use, to provide a safe and effective prevention and treatment option for avian influenza.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current anti-influenza medications (neuraminidase inhibitors, ion channel blockers) are used, then viral infection can be restrained, but the treatment cost increases significantly and side effects occur
Solution Approach 1:
The patent replaces expensive conventional medications with a traditional Chinese medicine composition made from readily available herbs (Houttuynia cordata, Lonicera japonica, Isatis indigotica, Sophora tonkinensis). This composition provides effective anti-influenza protection at a fraction of the cost of Western medications, making treatment accessible without significant financial burden.
Solution Approach 2:
The patent combines multiple traditional Chinese herbs into a composite medicinal formulation. This composite approach synergistically enhances anti-viral efficacy while reducing individual herb toxicity, providing both therapeutic effectiveness and safety without the severe side effects associated with conventional anti-influenza drugs.
2Adaptability or versatility
If highly pathogenic AIV strains emerge with antigenic shift, then new viral variants appear, but existing vaccines and medications become ineffective
Solution Approach 1:
The patent develops a multi-herb composition with broad-spectrum anti-viral activity that can address multiple influenza virus types and strains simultaneously. The formulation targets fundamental viral mechanisms rather than strain-specific antigens, providing universal protection that remains effective even when viral antigens shift or mutate.
Solution Approach 2:
The patent modifies the approach from targeting specific viral parameters (antigens) to targeting fundamental viral life cycle parameters (replication, entry, assembly). This parameter shift enables the medication to remain effective against antigenically diverse strains, as the mechanism of action is not dependent on conserved antigenic regions.
3Reliability
If conventional medications are used for prevention and treatment, then viral replication is inhibited, but drug resistance develops and effectiveness decreases
Solution Approach 1:
The patent employs traditional Chinese herbs as intermediary substances that modulate the host's immune response and create an unfavorable environment for viral replication without directly confronting the virus with high-pressure antiviral agents. This intermediary approach reduces selective pressure for resistance development while maintaining effective viral suppression.
Solution Approach 2:
The multi-herb composition acts on multiple targets and pathways simultaneously throughout the viral life cycle, creating continuous multi-faceted pressure that prevents the virus from adapting through single-point mutations. The synergistic herbal combination ensures sustained effectiveness without the resistance problems seen with monotherapies.
Data Source
AI summary
A Chinese traditional medicine composition for prevention and treatment of avian influenza is provided. Its active ingredients are consisted of: herba houttuyniae 21.4 wt. %, Caulis lonicerae japonicae 17.9 wt. %, radix isatidis 14.3 wt. %, male fern rhizome 10.7 wt. %, radix et rhizoma sophorae tonkinensis 7.1 wt. %, radix angelicae dahuricae 7.1 wt. %, rhizoma paridis 7.1 wt. %, herba artemisiae annuae 7.2 wt. %, and rhizoma iridis tectoris 7.2 wt. %. This Chinese traditional medicine composition could be made into any regular medicinal types, for example, oral solutions, tablets, capsules, pellets and injection solution, etc. Modified preparation methods for this Chinese traditional medicine composition, as well as the use of the same in preparation of medicines and health foods for prevention or treatment of avian influenza were also provided in present invention. This Chinese traditional medicine composition could effectively prevent and treat avian influenza. It was a safer, more easily-obtained, and inexpensive anti-avian influenza drug.